Polish Canoeist Banned For Two Years – Cliff Notes

Adam SeroczynskiPolish sprint canoer, Adam Dariusz Seroczynski, was suspended by the International Canoe Federation for using the banned anabolic steroid, clenbuterol. The canoeist finished fourth in Beijing in the flatwater K2 1,000-meter class with Mariusz Kujawski and was ineligible to compete at the London Olympics as the IOC guidelines bar any athlete who serves a doping-related ban of more than six months.

The 2000 Sydney Olympics bronze medalist competed in the Kayak double (K2) 1000m Men team event in Beijing Olympics and was asked on 22 August 2008 to provide a urine sample for a doping control.

The analytical report of the laboratory analysis of the A sample, prepared by the Head of the WADA Accredited Laboratory in Beijing, indicated the presence of Clenbuterol. On 4 September 2008, Adam Seroczynski requested for the analysis of the B sample that confirmed the finding of the A sample analysis and indicated the presence of Clenbuterol, a commonly used body fat and weight loss drug, in the B sample. Seroczynski said that he suspected food tampering by the “organizers”, which was rejected by the IOC saying his was the only case of an athlete doping in Beijing Olympics with Clenbuterol.

The IOC then disqualified Adam Seroczynski from the Kayak double (K2) 1000m Men event, where he had placed 4th and a two-year ban was imposed on him and his suspension runs through 3 February 2011. With the positive test, Seroczynski became the first canoeist to fail a doping test during the Summer Olympics. Born on March 13, 1974 in Olsztyn, Adam Seroczynski won three medals at the ICF Canoe Sprint World Championships with silver (K-2 1000 m: 2007) and two bronzes (K-1 1000 m: 2002, K-2 1000 m: 2006). He won a bronze medal in the K-4 1000 m event at Sydney in 2000 and competed in three Summer Olympics.

Marketed as Spiropent and Ventipulmin, Clenbuterol is a sympathomimetic amine used as a decongestant and bronchodilator by patients with breathing disorders. The chemical name of Clenbuterol (Clenbuterol Hydrochloride) is 4-Amino-alpha-[(tert-butylamino) methyl]-3, 5-dichlorobenzyl alcohol Monohydrochloride and the compound is featured by an oral bioavailability of 89 to 98 percent. Sold in the market under different names (Ventipulmin, Contraspasmina, Broncodil, and Spiropent), Clenbuterol has the molecular formula of C12H18 CI2N2O, active life of approximately 68 hours, and half life of about 36-39 hours. The fat loss drug has the molecular weight of 277.193 g/mol at the base.

The β2 agonist with some structural and pharmacological similarities to epinephrine and salbutamol can promote improvements in aerobic capacity, central nervous system stimulation, oxygen transportation, and an increase in blood pressure. Use of Clenbuterol is made by sportsmen to experience dramatic and nearly permanent gains in the context of muscle definition, weight loss, body fat loss, protein synthesis, and nitrogen retention. It is also admired by sportsmen as it promotes lean muscle mass and body strength while losing body fat and weight. Sportsmen using Clenbuterol can expect to lose 2-5 lbs per week and all these benefits can be availed by them without worrying about side effects of estrogens such as oily skin, bloating, acne, and gynecomastia.

Polish Canoeist Banned for Two Years

pdf_iconDownload in PDF: Polish Canoeist Banned For Two Years